View of 24. The prevalence of common adverse events after the 3rd dose of Comirnaty (Pfizer) COVID-19 vaccine among people vaccinated at the Vaccination site of Hanoi Medical University, 2022

Return to Article Details 24. The prevalence of common adverse events after the 3rd dose of Comirnaty (Pfizer) COVID-19 vaccine among people vaccinated at the Vaccination site of Hanoi Medical University, 2022 Download Download PDF